摘要
肿瘤血管的生成和发展在肿瘤的生长和恶化过程中起着关键作用。一类表达Tie2基因的单核细胞(TEM)通过一些生长因子和化学信号被募集到肿瘤组织中,旁分泌细胞因子促进肿瘤血管的生成和发展。TEM在促进肿瘤血管形成中起着重要作用,与血管内皮细胞祖细胞(EPC)不同的是,TEM只是在肿瘤的血管生成中起促进作用,但在肿瘤周围临近的正常组织中没有发现其存在,TEM被认为是一类肿瘤组织特异性的细胞。以TEM为载体细胞,通过TEM表达抗肿瘤药物,靶向递送的抗肿瘤药物能够有效的抑制肿瘤的生长和恶化。
Neovascularization is significant for tumor growth and progression to malignancy. Tie2 expressing monocytes (TEM) are recruited into tumors by several growth factors and chemokines, and promote tumor angiogenesis in a manner of paracrine. Moreover, TEM, while stimulating tumor angiogenesis, do not actively incorporate into blood vessels as endothelial progenitor cells ( EPC ), but are incorporated in all newforming blood vessel. TEM were found only in tumors and were missing in non-neoplastic tissues adjacent to tumors. Novel anticancer therapies that selectively target tumors by these cells have showed significant antitumor responses and near complete abrogation of metastasis.
出处
《国际免疫学杂志》
CAS
北大核心
2010年第1期5-8,共4页
International Journal of Immunology
基金
基金项目:国家自然科学基金资助项目(30860125)
关键词
TIE2
TEM
肿瘤靶向治疗
Tie2, Tie-2-expressing monocytes, Targeted antieancer therapy